PLoS ONE, 2023 Opioid use disorder (OUD) represents a public health crisis in the United States. Medication for opioid use disorder (MOUD) with buprenorphine in primary care is a proven OUD treatment strategy.
Douglas H Fernald +11 more
doaj +1 more source
Use of a Decision Aid in Medication Initiation Among Patients with Opioid Use Disorder and HIV [PDF]
, 2023 Opioid use disorder refers to the maladaptive use of prescribed or illicit opioids. This condition can be treated using pharmacotherapy referred to as medications for opioid use disorder (MOUD), but they are underutilized.
Gateley, Katrina
core +1 more source
Crafting Effective Regulatory Policies for Psychedelics: What Can Be Learned from the Case of Cannabis? [PDF]
, 2022 Importance: Medicaid is a key policy lever to improve opioid use disorder treatment, covering approximately 40% of Americans with opioid use disorder.
Abraham, Amanda J. +4 more
core +2 more sources
Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
Harm Reduction Journal, 2021 Background Recovery is a multidimensional process that includes health, quality of life, and citizenship. Recovery capital is a strengths-based concept representing the sum of an individual’s resources that support recovery.
Anna Beth Parlier-Ahmad +4 more
doaj +1 more source
The U.S. Should Increase Access to Medication for Opioid Use Disorder Among Incarcerated Individuals [PDF]
, 2023 Opioid Use Disorder (OUD) is among the most common medical diagnoses for people in jails and prisons. Those leaving incarceration without substance use treatment are 40 times more likely than the general public to have a fatal overdose, making it the ...
Nagle, Cody
core +1 more source
Predictors of Opioid and Alcohol Pharmacotherapy Initiation at Hospital Discharge Among Patients Seen by an Inpatient Addiction Consult Service [PDF]
, 2020 Background: Medications for opioid use disorder (MOUD) and alcohol use disorder (MAUD) are effective and under-prescribed. Hospital-based addiction consult services can engage out-of-treatment adults in addictions care.
Collins, Devin +6 more
core +2 more sources
Trends in Opioid Medication Adherence During the COVID-19 Pandemic: Retrospective Cohort Study
JMIR Public Health and Surveillance, 2023 BackgroundThe recent pandemic had the potential to worsen the opioid crisis through multiple effects on patients’ lives, such as the disruption of care. In particular, good levels of adherence with respect to medication for opioid
Amir Marashi +3 more
doaj +1 more source
Clinical leaders and providers perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs facilities. [PDF]
, 2021 BACKGROUND: Improving access to medication treatment of opioid use disorder (MOUD) is a national priority, yet common modifiable barriers (e.g., limited provider knowledge, negative beliefs about MOUD) often challenge implementation of MOUD delivery.
Blanchard, Brittany +13 more
core +1 more source
Cost Effectiveness of Buprenorphine when Used Long Term versus Short Term Use [PDF]
, 2023 Since 1999, nearly 841,000 people have died from a drug overdose (CDC, 2022), and substance use disorder (SUD) continues to be a crisis that faces communities across the country.
Hudgens, Ty
core +1 more source
Substance Abuse Treatment, Prevention, and Policy, 2023 Background Medications for opioid use disorder (MOUD; methadone, buprenorphine, naltrexone) are the most effective treatments for OUD, and MOUD is protective against fatal overdoses.
Jaclyn M. W. Hughto +8 more
doaj +1 more source